article thumbnail

STAT+: Sanofi plans to change payment terms for 340B hospitals

STAT

The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceutical company to disclose plans to change the way it will make payments. Right now, drug companies generally provide the discounts at the time of purchase.

article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database

STAT

The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5

article thumbnail

Is prescribing anticancer drugs by body surface area still relevant?

Hospital Pharmacy Europe

17 Clinical validation and standardising dosing Collaboration among pharmaceutical companies, regulatory bodies and healthcare providers is essential for developing standardised frameworks for precision dosing. appeared first on Hospital Pharmacy Europe. J Natl Cancer Inst 2018;110(10):116672.

article thumbnail

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

The hospitals and the payment plans would not use your generic drug if you weren’t therapeutically equivalent—we would exclude you,” Soefje said. In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said.

FDA
article thumbnail

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Pharmacy Times

8 Pharmacists also play a crucial role in access to medications for patients who might need payment assistance with assistance programs, communicating with insurers, or working with pharmaceutical companies to ensure that treatment is not delayed due to these barriers.